Back
ESC Premium Access

Novel Therapeutic Agents for Transthyretin Amyloidosis – Represented in NEJM by the ATTR-ACT, APOLLO, and NEURO-TTR trials.

Session: Highlights from the New England Journal of Medicine: editors’ choice
Topic: European Society of Cardiology
Speaker: Professor C. Rapezzi (Ferrara, IT)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Professor Claudio Rapezzi

University of Ferrara, Ferrara (Italy)
29 presentations
3 followers

2 more presentations in this session

Aspirin for the Primary Prevention of Cardiovascular Disease – Represented in NEJM by the ASPREE and ASCEND trials (and in Lancet by the ARRIVE trial).

Speaker: Professor J. Mcneil (Melbourne, AU)

Access
Slides
Video
Like
Thumbnail

Transcatheter Aortic Valve Replacement in Low-Risk Patients – Represented in NEJM by the PARTNER 3 and Evolut Low Risk trials.

Speaker: Doctor M. Mack (Dallas, US)

Access
Slides
Video
Like
Thumbnail

Access the full session

Highlights from the New England Journal of Medicine: editors’ choice

Speakers: Professor C. Rapezzi, Professor J. Mcneil, Doctor M. Mack
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources